The Efficacy of Vildagliptin Concomitant With Insulin Therapy in Type 2 Diabetic Subjects

BACKGROUND: In Japan, dipeptidyl peptidase 4 (DPP4) inhibitors have become standard therapeutic agents for type 2 diabetes, and numbers of patients receiving insulin therapy combined with DPP4 inhibitors, which is a highly effective regimen, are increasing. METHODS: In this study, we evaluated the e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med Res
Autors principals: Ito, Daisuke, Inoue, Kazuyuki, Kaneko, Kimie, Yanagisawa, Morifumi, Sumita, Takashi, Ikegami, Yuichi, Awata, Takuya, Ishida, Hitoshi, Katayama, Shigehiro, Inukai, Kouichi
Format: Artigo
Idioma:Inglês
Publicat: Elmer Press 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356089/
https://ncbi.nlm.nih.gov/pubmed/25780477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2057w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars